ST
NVAX icon

Spot Trading’s Novavax NVAX Stock Holding History

Spot Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,775
Closed -$74K – 3035
2016
Q3 		$74K Sell
1,775
-765
-30% -$98.8K ﹤0.01% 2511
2016
Q2 		$369K Buy
2,540
+1,270
+100% +$146K 0.01% 1820
2016
Q1 		$131K Sell
1,270
-1,535
-55% -$165K ﹤0.01% 2438
2015
Q4 		$471K Buy
2,805
+1,250
+80% +$192K ﹤0.01% 1961
2015
Q3 		$220K Buy
1,555
+1,250
+410% +$280K ﹤0.01% 2633
2015
Q2 		$68K Buy
305
+285
+1,425% +$50.1K ﹤0.01% 3201
2015
Q1 		$3K Sell
20
-615
-97% -$99.9K ﹤0.01% 3709
2014
Q4 		$75K Buy
+635
New +$66.4K ﹤0.01% 3330
2014
Q3 		– Sell
-800
Closed -$74K – 4601
2014
Q2 		$74K Hold
800
– – ﹤0.01% 3809
2014
Q1 		$72K Buy
+800
New +$89.4K ﹤0.01% 3539

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spot Trading's NVAX Position: Q1 2017 in Review

Spot Trading sold out of Novavax (NVAX) in Q1 2017, closing a stake of 498 shares — an estimated $13K sold.

Spot Trading first reported a position in NVAX in Q4 2013 and held it in 11 quarters. The position peaked at $1.03M in Q3 2014. 129 funds tracked by Wall St. Rank hold NVAX as of Q1 2017.

  • Spot Trading reported no remaining Novavax position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 498 Novavax shares in Q1 2017, an estimated $13K.
  • Spot Trading first reported a position in Novavax in Q4 2013 and held it in 11 quarters.
  • Spot Trading's Novavax position peaked at $1.03M in Q3 2014.
  • 129 funds tracked by Wall St. Rank held Novavax as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.